Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

McMaster University

$105,000.00

Living clinical practice guideline on drugs for type 2 diabetes mellitus

FY 2023-24

Summary
Clinicians rely on guidelines to inform their practice when caring for patients. However, guidelines have long suffered from numerous limitations, making the recommendations they provide less trustworthy. Moreover, guidelines have chronically struggled to account for a large number of treatment alternatives together, and to reflect the latest available evidence. Efforts to produce trustworthy guidelines that are current and reflect treatment decisions between numerous treatments are required. Diabetes is common and is associated with significant heart and kidney-related complications. Several new treatment alternatives to reduce these complications exist. The effectiveness of these treatments compared to one another, however, has not been evaluated. Here, we propose a living network meta-analysis for drug treatments for type 2 diabetes, and an international living clinical practice guideline to inform clinicians regarding most effective treatments. Network meta-analysis facilitates comparisons across multiple treatment options. Living meta-analyses and living guidelines allow for iterative updates to evidence and recommendations to ensure both are current and accurate. Both processes adhere to GRADE, a structured framework for appraising certainty in evidence and recommendations. The guideline will involve recruitment of an international panel including patient partners, clinical experts and research methodologists. Clinically-important questions needing guidance will be identified by the panel. The meta-analysis will be conducted by an independent team of methodologists to synthesize available evidence. The guideline panel will then be convened to review evidence and utilize structured frameworks to move from evidence to recommendations. Guidance will be prepared and disseminated via a major medical journal with an international readership, and a user-friendly online platform (MAGICapp). The guideline has the potential to change clinical practice worldwide.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
496460
Name
Agarwal Arnav
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Doctoral Research Awards - B
Projecttitle
Living clinical practice guideline on drugs for type 2 diabetes mellitus
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Clinical Practice Guideline; Diabetes; Drugs; Living Guideline; Network Meta-Analysis; Pharmacotherapies; Systematic Review; Treatment
Abstract
Clinicians rely on guidelines to inform their practice when caring for patients. However, guidelines have long suffered from numerous limitations, making the recommendations they provide less trustworthy. Moreover, guidelines have chronically struggled to account for a large number of treatment alternatives together, and to reflect the latest available evidence. Efforts to produce trustworthy guidelines that are current and reflect treatment decisions between numerous treatments are required. Diabetes is common and is associated with significant heart and kidney-related complications. Several new treatment alternatives to reduce these complications exist. The effectiveness of these treatments compared to one another, however, has not been evaluated. Here, we propose a living network meta-analysis for drug treatments for type 2 diabetes, and an international living clinical practice guideline to inform clinicians regarding most effective treatments. Network meta-analysis facilitates comparisons across multiple treatment options. Living meta-analyses and living guidelines allow for iterative updates to evidence and recommendations to ensure both are current and accurate. Both processes adhere to GRADE, a structured framework for appraising certainty in evidence and recommendations. The guideline will involve recruitment of an international panel including patient partners, clinical experts and research methodologists. Clinically-important questions needing guidance will be identified by the panel. The meta-analysis will be conducted by an independent team of methodologists to synthesize available evidence. The guideline panel will then be convened to review evidence and utilize structured frameworks to move from evidence to recommendations. Guidance will be prepared and disseminated via a major medical journal with an international readership, and a user-friendly online platform (MAGICapp). The guideline has the potential to change clinical practice worldwide.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Agarwal, Arnav
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McMaster University - $105,000 Grant (2023-24) | Canada Spends